Massachusetts Financial Services’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $57.6K | Buy |
|
|||||
|
2025
Q2 | $40.8K | Sell |
|
|||||
|
2025
Q1 | $548K | Sell |
|
|||||
|
2024
Q4 | $25.4M | Buy |
|
|||||
|
2024
Q3 | $29.9M | Sell |
|
|||||
|
2024
Q2 | $32.6M | Buy |
|
|||||
|
2024
Q1 | $34.3M | Sell |
|
|||||
|
2023
Q4 | $39.4M | Sell |
|
|||||
|
2023
Q3 | $81.5M | Sell |
|
|||||
|
2023
Q2 | $139M | Sell |
|
|||||
|
2023
Q1 | $165M | Sell |
|
|||||
|
2022
Q4 | $187M | Sell |
|
|||||
|
2022
Q3 | $361M | Buy |
|
|||||
|
2022
Q2 | $361M | Buy |
|
|||||
|
2022
Q1 | $316M | Buy |
|
|||||
|
2021
Q4 | $335M | Buy |
|
|||||
|
2021
Q3 | $272M | Buy |
|
|||||
|
2021
Q2 | $209M | Sell |
|
|||||
|
2021
Q1 | $192M | Buy |
|
|||||
|
2020
Q4 | $119M | Buy |
|